Pure Global AI
Disease / condition

Chronic Hepatitis C clinical trials

Free access to 299 studies10+ countriesUpdated daily3 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
299
Total trials
10+
Countries
10+
Sponsors
3
Recruiting
By phase
N/A96
Phase 269
Phase 343
Phase 438
Phase 133
By status
Completed213
Unknown38
Terminated22
Withdrawn12
Ongoing3
Top countries
United States of America48
China18
France14
Japan14
Egypt13
Top sponsors
Merck Sharp & Dohm...19
Bristol-Myers Squi...15
AbbVie14
Gilead Sciences9
Bristol-Myers Squi...8
Recent trials
Latest clinical trials for Chronic Hepatitis C
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders
Helwan University · Egypt
NCT04695769Recruiting
Phase
Phase 4
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
Beijing Ditan Hospital · China
NCT04301882
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
Sunshine Lake Pharma Co., Ltd. · China
NCT04232514Completed
Phase
Phase 1
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
Sunshine Lake Pharma Co., Ltd. · China
NCT04202952Completed
Phase
Phase 1/2
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
Sunshine Lake Pharma Co., Ltd. · China
NCT04201275Completed
Phase
Phase 1
Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients
University of North Carolina, ... · United States of America
NCT04198584Completed
Metabolic Changes in Chronic HCV Patients Receiving DAAS
Ain Shams University · Egypt
NCT04211844
Untitled Trial
Jumei Foundation · China
ChiCTR1900027288Not yet recr...
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Beijing Ditan Hospital · China
NCT04071353
Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil
Hospital de Clinicas de Porto ... · Brazil
NCT04039698Not yet recr...
The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects
Sunshine Lake Pharma Co., Ltd. · China
NCT03903081Completed
Phase
Phase 1
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
Third Affiliated Hospital, Sun...
NCT03887637
Untitled Trial
Beijing You'an Hospital, Capit... · China
ChiCTR1900020845Recruiting
Untitled Trial
The First Hospital of Jilin Un... · China
ChiCTR1800019721Not yet recr...
A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study
American Research Corporation
NCT03710252Completed
Phase
Phase 4
Real Life Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt
ANRS, Emerging Infectious Dise... · Egypt
NCT03510637
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
Bristol-Myers Squibb · China
NCT03500562Terminated
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
Cocrystal Pharma, Inc. · United States of America
NCT03501550Completed
Phase
Phase 2
Re-treatment of HCV Following DAA Failure
Sanjay Gandhi Postgraduate Ins... · India
NCT03483987Terminated
Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosis
Department of infectious Disea...
2017-005179-21
View all 299 trials →
About this profile

Access comprehensive clinical trial information for Chronic Hepatitis C through Pure Global AI's free database. This collection includes 299 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 3 trials are actively recruiting participants.

Research for Chronic Hepatitis C is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Merck Sharp & Dohme LLC and Bristol-Myers Squibb. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 299 clinical trials studying Chronic Hepatitis C, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Merck Sharp & Dohme LLC, Bristol-Myers Squibb, AbbVie, among others.